1. Gilead says remdesivir cut risk of COVID patient death in clinical trial — BioNTech-Pfizer COVID vaccine expected to be ready for approval by year end — LEO Pharma eyeing 2021 launch for Dupixent rival — See more on our front page news Stay updated with the latest pharma-related coronavirus news on our new page
    Dismiss Notice
  2. Please take our quick survey on how COVID-19 is impacting your job It will only take a minute or two to respond. The survey is confidential, and does not require registration. Thank you in advance for your participation. We will provide regular updates on results as responses accumulate.
    Dismiss Notice

AST division

Discussion in 'Covidien' started by anonymous, Sep 8, 2016 at 11:06 PM.

  1. anonymous

    anonymous Guest

    Noone is hitting plan and senior management has no intention on changing that. New hire moron RMs, without any understanding of the business are breathing down our neck for metrics they don't know shit about. Yeah!
     
  2. anonymous

    anonymous Guest

    At least you get to drive an Equinox.
     
  3. anonymous

    anonymous Guest

    though it is enjoyable watching the idiots from valleylab torpedo the entire book of business in less than five years time. bravo retards
     
  4. anonymous

    anonymous Guest

     
  5. anonymous

    anonymous Guest

    It is a travesty to see what is happening to this place all over again. We are plagued with backorders, Manufacturing shortfalls, and delayed launch dates.

    It hasn't been this way since CB and BH blew up Skip's fireside chat tears ago. The promise? That we would never be that disfunctional again. Well, things got better, we wemt through a difficult but effective reorg with Hercules and things were fairly good,

    Now BH and CB have drifted away from the field and left a bunch of disingenuous, uninspiring leaders in their wake. Those leaders took all that was done well with Hercules and threw it out the window with the Hernia reorg. They left the field team in shock and surprise with abysmal training and a third bag to carry. FOR THE SAME COMP! or slightly more for the few supers. Then they made no adjustment to account for change fatigue or ramp up in their overzealous forecasts and trickle down quota tasking.

    Combine that with the manufacturing & marketing ineptitude and there's no wonder as to why we're in crisis mode. Typical response has been to whip the horse rather than recognize that the wagon wheel has fallen off.

    My only hope is that management will realize that the plan is flawed and not the executors. Fix the plan before we lose too many good field sales people and use the rest of FY17 to get the wagon fixed.... When the wagon (comp, manufacturing & marketing) is repaired we'll be here to pull just as hard as we have the last 5 years. You neglect to fix the wagon you'll end up with broken horses.
     
  6. anonymous

    anonymous Guest

    You rep commodity products that are sold according to GPO contracts. There is no room for meaningful innovation in any AST products. Adoption of robotics and reprocessing are taking share and you have no recourse. The US is saturated and focus for growth of AST products has shifted to emerging markets. Best to find a better opportunity.
     
  7. anonymous

    anonymous Guest

    This sums up reality. Great post
     
  8. anonymous

    anonymous Guest

     
  9. anonymous

    anonymous Guest

    Spot on.

    Signed,
    A broken horse



     
  10. anonymous

    anonymous Guest

    HET will be your salvation.
     
  11. anonymous

    anonymous Guest

    So now the AST conversation turns...

    Q1: How are we gonna integrate selling tackers into what we're already doing?

    Q2: Nobody's making their number, backorders are awful and even though I don't sell e-stitch anymore, I'm catching all the crap from unhappy surgeons over it.

    Q3: I wonder who in Sr. mgmt is gonna get fired at the end of the year?

    Q4: (To be announced later)
     
  12. anonymous

    anonymous Guest

    How are things at AST? Are heads rolling yet?
     
  13. anonymous

    anonymous Guest

     
  14. anonymous

    anonymous Guest

    Ethicon are taking share everyday!
     
  15. anonymous

    anonymous Guest

    Eager beaver newly hired EES rep, yeah guys!!
     
  16. anonymous

    anonymous Guest

    ...and here we are, eight months later.

    And NOTHING has changed for the better. When will the madness end?
     
  17. anonymous

    anonymous Guest

    BiZact, baby!
     
  18. anonymous

    anonymous Guest

    Madness
     
  19. anonymous

    anonymous Guest


    Super super well said
     
  20. anonymous

    anonymous Guest